Drug Price Trends for ICLEVIA

Average Pharmacy Cost for ICLEVIA

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-83	0.14105	EACH	2024-12-18
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-94	0.14105	EACH	2024-12-18
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-83	0.10576	EACH	2024-11-20
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-94	0.10576	EACH	2024-11-20
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-83	0.19156	EACH	2024-10-23
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-94	0.19156	EACH	2024-10-23
ICLEVIA 0.15 MG-0.03 MG TABLET	65862-0865-83	0.22081	EACH	2024-09-18

Market Analysis and Price Projections for Iclevia

Introduction to Iclevia

Iclevia, a combination oral contraceptive (COC) containing levonorgestrel and ethinyl estradiol, is indicated for use by females of reproductive potential to prevent pregnancy. Understanding the market dynamics and price projections for Iclevia involves analyzing various factors, including market trends, competition, regulatory environment, and consumer behavior.

Market Trends in Contraceptives

The global contraceptive market is experiencing significant growth, driven by increasing awareness of reproductive health, rising educational achievements, and government initiatives to reduce unwanted pregnancies. The market was valued at USD 29.57 billion in 2023 and is expected to grow at a CAGR of 5.92% from 2024 to 2030[2].

Segmentation and Market Share

The contraceptive market is segmented into various products, including pills, patches, and injectables. The contraceptive pill segment, which includes Iclevia, held the largest share of the market in 2023. This is due to the convenience, effectiveness, and affordability of contraceptive pills. According to the Family Planning 2023 report by the Clinton Health Access Initiative, public sector industry volumes for contraceptive pills accounted for around 147 million in 2022 across 84 countries[2].

Regional Market Analysis

North America

The North America contraceptive market, particularly the U.S., holds a significant share of the global market. The region's high awareness of reproductive health, preference for modern contraceptives, and government policies such as the Affordable Care Act, which mandates insurance coverage for contraceptive methods, contribute to its large market share. Iclevia, being a widely used contraceptive pill, benefits from these favorable market conditions[2].

Europe

In Europe, the UK contraceptive market is expected to grow significantly due to the increasing prevalence of STDs and growing awareness of the need to prevent unplanned pregnancies. Government policies, such as the National Health Service (NHS) providing free contraception, enhance access to a wide range of contraception methods, including Iclevia[2].

Price Dynamics

Current Pricing

The cost for Iclevia (extended cycle 30 mcg-0.15 mg) oral tablets is around $134 for a supply of 273 tablets, depending on the pharmacy. This price is for cash-paying customers and does not include discounts or insurance plans[3].

Discounts and Assistance Programs

To make Iclevia more affordable, various discount programs and patient assistance plans are available. For example, the Drugs.com Discount Card can save consumers up to 80% on prescription medicines, including Iclevia[3].

Price Projections

Pharmacy Market Outlook

While specific price projections for Iclevia are not available, the overall pharmacy market outlook suggests stable to moderate price inflation. The Vizient Pharmacy Market Outlook for 2025 projects a 0.00% overall drug price inflation rate, indicating that prices are likely to remain stable or see minimal increases[4].

Generic Competition

The availability of generic versions of Iclevia (levonorgestrel and ethinyl estradiol) can impact pricing. Generic drugs are generally more affordable, which could lead to competitive pricing pressures on branded products like Iclevia[3].

Regulatory and Health Policy Impact

Government policies and healthcare reforms play a crucial role in shaping the market for contraceptives. Policies that mandate insurance coverage for contraceptive methods, such as the Affordable Care Act in the U.S., can increase access and affordability, thereby influencing demand and pricing[2].

Healthcare Reforms and Access

In developed markets, governments are implementing healthcare reforms to improve access to innovative drugs, including contraceptives. These reforms can enhance market growth by making high-cost innovative drugs more accessible, although they may also introduce cost containment measures that could affect pricing[1].

Consumer Behavior and Awareness

Increasing awareness of reproductive health and the growing preference for modern contraception methods drive the demand for products like Iclevia. Consumer education programs and initiatives aimed at reducing unwanted pregnancies further boost the market[2].

Challenges and Opportunities

Competition from Other Contraceptives

The contraceptive market is highly competitive, with various products available. Iclevia faces competition from other oral contraceptives, as well as from other forms of contraception like patches, injectables, and long-acting reversible contraceptives (LARCs)[2].

Innovations and New Product Launches

The pharmaceutical industry is witnessing the launch of innovative products, including new contraceptive methods. These innovations can both compete with and complement existing products like Iclevia, influencing market dynamics and pricing[1].

Key Takeaways

• Market Growth: The global contraceptive market is expected to grow at a CAGR of 5.92% from 2024 to 2030.
• Regional Performance: North America and Europe, particularly the U.S. and UK, are significant markets for Iclevia.
• Pricing: Current prices for Iclevia are around $134 for a 273-tablet supply, with potential savings through discount programs.
• Price Projections: Stable to minimal price inflation is expected in the pharmacy market.
• Regulatory Impact: Government policies and healthcare reforms significantly influence access and affordability.
• Consumer Behavior: Increasing awareness and preference for modern contraception drive demand.

FAQs

1. What is Iclevia used for?

Iclevia is a combination oral contraceptive (COC) used by females of reproductive potential to prevent pregnancy[5].

2. How much does Iclevia cost?

The cost for Iclevia (extended cycle 30 mcg-0.15 mg) oral tablets is around $134 for a supply of 273 tablets, depending on the pharmacy[3].

3. Are there any discount programs available for Iclevia?

Yes, discount programs like the Drugs.com Discount Card can save consumers up to 80% on prescription medicines, including Iclevia[3].

4. What are the key drivers of the contraceptive market?

The key drivers include increasing awareness of reproductive health, rising educational achievements, and government initiatives to reduce unwanted pregnancies[2].

5. How does the availability of generic versions impact Iclevia's pricing?

The availability of generic versions can lead to competitive pricing pressures, making branded products like Iclevia potentially more affordable through price reductions or discounts[3].

Cited Sources:

1. IQVIA Quarterly Pharmaceutical Market Outlook - November 2023
2. Contraceptive Market Size, Share And Growth Report, 2030 - Grand View Research
3. Iclevia Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
4. Pharmacy Market Outlook Summer 2024 - Vizient Inc.
5. Iclevia: Package Insert / Prescribing Information - Drugs.com